arrow
E

Erin Salo-Mullen

Memorial Sloan Kettering Cancer Center
H指数:27
被引数:3,952

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry
CANCER
IF5.1
2023-10-276
PRE
Comprehensive analysis of germline drivers in endometrial cancer
2023-02-069
OA
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants

在具有致病性种系变异的泛癌症患者中,种族/种族在癌症遗传学护理方面的差异

CANCER
IF5.1
2022-08-3022
OAAI
Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
2021-11-0142
OAAI
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers
2021-08-1894
OA
Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes
CANCER
IF5.1
2021-08-0533
OAAI
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome
2021-07-089
OA
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes
2021-03-2342
OAAI
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
2021-02-15101
OAAI
Germline mutation prevalence in young adults with cancer
2020-08-156
PRE
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
2018-02-28176
OAAI
Phase 1 Trial Evaluating Cisplatin, Gemcitabine, and Veliparib in 2 Patient Cohorts: Germline BRCA Mutation Carriers and Wild-Type BRCA Pancreatic Ductal Adenocarcinoma
CANCER
IF5.1
2018-01-1691
OAAI
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
2018-01-01131
OAAI